ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Allogene Therapeutics Inc

Allogene Therapeutics Inc (ALLO)

2.02
0.09
(4.66%)
Closed March 06 3:00PM
1.93
-0.09
(-4.46%)
After Hours: 6:55PM

Allogene Therapeutics Inc Financial Summary

The current ALLO market cap is 404.67M. The company's latest EPS is USD -1.5608 and P/E is -1.30.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 43k-44k22k00
Operating Income -62.98M-71.93M-69.5M-71.43M-71.77M
Net Income -61.32M-89.26M-65M-66.36M-66.29M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0038.49M243k95k
Operating Income -202.01M-258.24M-255.79M-335.45M-314.49M
Net Income -184.59M-250.22M-257.01M-332.63M-327.27M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 712.33M642.84M586.35M646.88M589.12M
Total Liabilities 129.22M130.6M124.98M131.85M125.37M
Total Equity 583.1M512.23M461.37M515.04M463.75M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 717.8M1.23B1.04B817.08M642.84M
Total Liabilities 88.78M148.21M122.23M151.21M130.6M
Total Equity 629.02M1.08B916.41M665.87M512.23M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -184.03M-237.73M-55.9M-119.49M-163.6M
Investing 95.83M163.29M22.13M96.75M20.75M
Financing 95.54M95.7M1.65M110.25M110.93M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -137.35M-115.09M-184.81M-220.52M-237.73M
Investing 164.08M-505.12M163.66M106.16M163.29M
Financing 58.96M633.59M11.96M2.95M95.7M
Market Cap 404.67M
Price to Earnings Ratio -1.30
Price to Sales Ratio 4.06k
Price to Cash Ratio 5.12
Price to Book Ratio 0.83
Dividend Yield -

Share Statistics

Shares Outstanding 209.67M
Average Volume (1 week) 3.51M
Average Volume (1 Month) 10.31M
52 Week Change -64.59%
52 Week High 5.775
52 Week Low 1.32
Spread (Intraday) 0.09 (4.43%)

Company Info

Company Name Allogene Therapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.allogene.com
Industry biological pds,ex diagnstics (2836)